- Home
- CPBI vs XLO Comparison
CPBI vs XLO Comparison
Compare CPBI & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPBI
- XLO
- Stock Information
- Founded
- CPBI 2023
- XLO 2016
- Country
- CPBI United States
- XLO United States
- Employees
- CPBI N/A
- XLO N/A
- Industry
- CPBI
- XLO Biotechnology: Pharmaceutical Preparations
- Sector
- CPBI
- XLO Health Care
- Exchange
- CPBI Nasdaq
- XLO Nasdaq
- Market Cap
- CPBI 53.6M
- XLO 43.5M
- IPO Year
- CPBI N/A
- XLO 2021
- Fundamental
- Price
- CPBI $14.49
- XLO $0.99
- Analyst Decision
- CPBI
- XLO Buy
- Analyst Count
- CPBI 0
- XLO 1
- Target Price
- CPBI N/A
- XLO $4.00
- AVG Volume (30 Days)
- CPBI 16.2K
- XLO 457.5K
- Earning Date
- CPBI 01-01-0001
- XLO 11-07-2024
- Dividend Yield
- CPBI N/A
- XLO N/A
- EPS Growth
- CPBI N/A
- XLO N/A
- EPS
- CPBI 0.89
- XLO N/A
- Revenue
- CPBI $18,262,000.00
- XLO $4,620,000.00
- Revenue This Year
- CPBI N/A
- XLO N/A
- Revenue Next Year
- CPBI N/A
- XLO $428.64
- P/E Ratio
- CPBI $16.25
- XLO N/A
- Revenue Growth
- CPBI 37.65
- XLO N/A
- 52 Week Low
- CPBI $9.40
- XLO $0.49
- 52 Week High
- CPBI $15.00
- XLO $1.93
- Technical
- Relative Strength Index (RSI)
- CPBI 69.35
- XLO 49.53
- Support Level
- CPBI $14.59
- XLO $0.98
- Resistance Level
- CPBI $14.89
- XLO $1.15
- Average True Range (ATR)
- CPBI 0.20
- XLO 0.16
- MACD
- CPBI 0.02
- XLO -0.03
- Stochastic Oscillator
- CPBI 71.07
- XLO 18.59
About CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists primarily of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in our primary market area, as well as commercial real estate loans.
About XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).